by Reavis Daniel Moore | May 1, 2024
Patient Reported Outcomes and Experience Measurers. Patient centric mood monitoring system used daily and as assessment tool during treatment, and follow-up.
by Reavis Daniel Moore | May 1, 2024
A cross-sectional nationwide survey of adults in the USA in 2021. Records captures the rate of psychedelic use, comorbid conditions, mental and physical health, and factors predictive of psychedelic use were assessed.
by Reavis Daniel Moore | May 1, 2024
Private clinic health records capturing longitudinal and comprehensive patient intake, biomarkers, labs, procedures and clinical notes targeted at capturing the patient journey in the processes of personalizing optimizing their care for various chronic health...
by Reavis Daniel Moore | May 1, 2024
Dataset from a double-blind controlled study. Studying the effects of four repeated doses of LSD titrate (13 or 26 μg) or placebo, administered to healthy adults at 3–4 day intervals, on mood, cognitive performance and responses to emotional tasks. Assesment was done...
by Reavis Daniel Moore | May 1, 2024
Online survey about the impact of the coronavirus pandemic on mental health in the U.S.
Recent Comments